Literature DB >> 26211463

β-Arrestin scaffolds and signaling elements essential for the obestatin/GPR39 system that determine the myogenic program in human myoblast cells.

Icía Santos-Zas1,2, Uxía Gurriarán-Rodríguez1,3, Tania Cid-Díaz1,2, Gabriela Figueroa1, Jessica González-Sánchez1,2, Mónica Bouzo-Lorenzo1,2, Carlos S Mosteiro1,2, José Señarís4, Felipe F Casanueva2,5, Xesús Casabiell6, Rosalía Gallego7, Yolanda Pazos1,2, Vincent Mouly8, Jesús P Camiña9,10.   

Abstract

Obestatin/GPR39 signaling stimulates skeletal muscle repair by inducing the expansion of satellite stem cells as well as myofiber hypertrophy. Here, we describe that the obestatin/GPR39 system acts as autocrine/paracrine factor on human myogenesis. Obestatin regulated multiple steps of myogenesis: myoblast proliferation, cell cycle exit, differentiation and recruitment to fuse and form multinucleated hypertrophic myotubes. Obestatin-induced mitogenic action was mediated by ERK1/2 and JunD activity, being orchestrated by a G-dependent mechanism. At a later stage of myogenesis, scaffolding proteins β-arrestin 1 and 2 were essential for the activation of cell cycle exit and differentiation through the transactivation of the epidermal growth factor receptor (EGFR). Upon obestatin stimulus, β-arrestins are recruited to the membrane, where they functionally interact with GPR39 leading to Src activation and signalplex formation to EGFR transactivation by matrix metalloproteinases. This signalplex regulated the mitotic arrest by p21 and p57 expression and the mid- to late stages of differentiation through JNK/c-Jun, CAMKII, Akt and p38 pathways. This finding not only provides the first functional activity for β-arrestins in myogenesis but also identify potential targets for therapeutic approaches by triggering specific signaling arms of the GPR39 signaling involved in myogenesis.

Entities:  

Keywords:  Obestatin signaling; Skeletal muscle; Skeletal muscle regeneration

Mesh:

Substances:

Year:  2015        PMID: 26211463     DOI: 10.1007/s00018-015-1994-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  85 in total

1.  Establishment of a human skeletal muscle-derived cell line: biochemical, cellular and electrophysiological characterization.

Authors:  Ori Rokach; Nina D Ullrich; Martin Rausch; Vincent Mouly; Haiyan Zhou; Francesco Muntoni; Francesco Zorzato; Susan Treves
Journal:  Biochem J       Date:  2013-10-15       Impact factor: 3.857

2.  Phosphorylated heat shock protein 27 represses growth of hepatocellular carcinoma via inhibition of extracellular signal-regulated kinase.

Authors:  Rie Matsushima-Nishiwaki; Shinji Takai; Seiji Adachi; Chiho Minamitani; Eisuke Yasuda; Takahiro Noda; Kanefusa Kato; Hidenori Toyoda; Yuji Kaneoka; Akihiro Yamaguchi; Takashi Kumada; Osamu Kozawa
Journal:  J Biol Chem       Date:  2008-05-13       Impact factor: 5.157

Review 3.  Satellite cells and the muscle stem cell niche.

Authors:  Hang Yin; Feodor Price; Michael A Rudnicki
Journal:  Physiol Rev       Date:  2013-01       Impact factor: 37.312

4.  Pax-7 up-regulation inhibits myogenesis and cell cycle progression in satellite cells: a potential mechanism for self-renewal.

Authors:  Hugo C Olguin; Bradley B Olwin
Journal:  Dev Biol       Date:  2004-11-15       Impact factor: 3.582

5.  Preproghrelin expression is a key target for insulin action on adipogenesis.

Authors:  Uxía Gurriarán-Rodríguez; Omar Al-Massadi; Ana Belén Crujeiras; Carlos S Mosteiro; María Amil-Diz; Daniel Beiroa; Rubén Nogueiras; Luisa María Seoane; Rosalía Gallego; Yolanda Pazos; Felipe F Casanueva; Jesús P Camiña
Journal:  J Endocrinol       Date:  2011-06-20       Impact factor: 4.286

6.  Distinct actions of Akt1 and Akt2 in skeletal muscle differentiation.

Authors:  Peter Rotwein; Elizabeth M Wilson
Journal:  J Cell Physiol       Date:  2009-05       Impact factor: 6.384

7.  Short-term calorie restriction enhances skeletal muscle stem cell function.

Authors:  Massimiliano Cerletti; Young C Jang; Lydia W S Finley; Marcia C Haigis; Amy J Wagers
Journal:  Cell Stem Cell       Date:  2012-05-04       Impact factor: 24.633

Review 8.  Cancer cachexia: mediators, signaling, and metabolic pathways.

Authors:  Kenneth C H Fearon; David J Glass; Denis C Guttridge
Journal:  Cell Metab       Date:  2012-07-12       Impact factor: 27.287

Review 9.  Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors.

Authors:  Eric Reiter; Seungkirl Ahn; Arun K Shukla; Robert J Lefkowitz
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011-09-19       Impact factor: 13.820

Review 10.  The ADAM metalloproteinases.

Authors:  Dylan R Edwards; Madeleine M Handsley; Caroline J Pennington
Journal:  Mol Aspects Med       Date:  2008-08-15
View more
  11 in total

1.  Ghrelin knockout mice display defective skeletal muscle regeneration and impaired satellite cell self-renewal.

Authors:  Elia Angelino; Simone Reano; Alessandro Bollo; Michele Ferrara; Marilisa De Feudis; Hana Sustova; Emanuela Agosti; Sara Clerici; Flavia Prodam; Catherine-Laure Tomasetto; Andrea Graziani; Nicoletta Filigheddu
Journal:  Endocrine       Date:  2018-05-30       Impact factor: 3.633

2.  Obestatin Increases the Regenerative Capacity of Human Myoblasts Transplanted Intramuscularly in an Immunodeficient Mouse Model.

Authors:  Icia Santos-Zas; Elisa Negroni; Kamel Mamchaoui; Carlos S Mosteiro; Rosalia Gallego; Gillian S Butler-Browne; Yolanda Pazos; Vincent Mouly; Jesus P Camiña
Journal:  Mol Ther       Date:  2017-07-24       Impact factor: 11.454

Review 3.  G Protein-Coupled Receptor Signaling Through β-Arrestin-Dependent Mechanisms.

Authors:  Pierre-Yves Jean-Charles; Suneet Kaur; Sudha K Shenoy
Journal:  J Cardiovasc Pharmacol       Date:  2017-09       Impact factor: 3.105

4.  Skeletal muscle characteristics are preserved in hTERT/cdk4 human myogenic cell lines.

Authors:  Matthew Thorley; Stéphanie Duguez; Emilia Maria Cristina Mazza; Sara Valsoni; Anne Bigot; Kamel Mamchaoui; Brennan Harmon; Thomas Voit; Vincent Mouly; William Duddy
Journal:  Skelet Muscle       Date:  2016-12-08       Impact factor: 4.912

5.  Obestatin controls skeletal muscle fiber-type determination.

Authors:  Icía Santos-Zas; Tania Cid-Díaz; Jessica González-Sánchez; Uxía Gurriarán-Rodriguez; Carlos Seoane-Mosteiro; Begoña Porteiro; Rubén Nogueiras; Xesús Casabiell; José Luis Relova; Rosalía Gallego; Vincent Mouly; Yolanda Pazos; Jesus P Camiña
Journal:  Sci Rep       Date:  2017-05-18       Impact factor: 4.379

6.  Improvement of Duchenne muscular dystrophy phenotype following obestatin treatment.

Authors:  Jessica González-Sánchez; Agustín Sánchez-Temprano; Tania Cid-Díaz; Regina Pabst-Fernández; Carlos S Mosteiro; Rosalía Gallego; Ruben Nogueiras; Xesús Casabiell; Gillian S Butler-Browne; Vincent Mouly; José Luis Relova; Yolanda Pazos; Jesús P Camiña
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-09-14       Impact factor: 12.910

7.  microRNA-1914, which is regulated by lncRNA DUXAP10, inhibits cell proliferation by targeting the GPR39-mediated PI3K/AKT/mTOR pathway in HCC.

Authors:  Liankang Sun; Liang Wang; Tianxiang Chen; Bowen Yao; Yufeng Wang; Qing Li; Wei Yang; Zhikui Liu
Journal:  J Cell Mol Med       Date:  2019-10-01       Impact factor: 5.310

Review 8.  The Role of β-Arrestins in Regulating Stem Cell Phenotypes in Normal and Tumorigenic Cells.

Authors:  Georgios Kallifatidis; Kenza Mamouni; Bal L Lokeshwar
Journal:  Int J Mol Sci       Date:  2020-12-07       Impact factor: 5.923

9.  Obestatin controls the ubiquitin-proteasome and autophagy-lysosome systems in glucocorticoid-induced muscle cell atrophy.

Authors:  Tania Cid-Díaz; Icía Santos-Zas; Jessica González-Sánchez; Uxía Gurriarán-Rodríguez; Carlos S Mosteiro; Xesús Casabiell; Tomás García-Caballero; Vincent Mouly; Yolanda Pazos; Jesús P Camiña
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-07-03       Impact factor: 12.910

10.  Orchestration of Intracellular Circuits by G Protein-Coupled Receptor 39 for Hepatitis B Virus Proliferation.

Authors:  Kaku Goto; Hironori Nishitsuji; Masaya Sugiyama; Nao Nishida; Masashi Mizokami; Kunitada Shimotohno
Journal:  Int J Mol Sci       Date:  2020-08-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.